Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.

Publication Year: 2023

DOI:
10.1007/s13167-023-00324-6

PMCID:
PMC10201107

PMID:
37275547

Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalNot applicable. Consent to participateNot applicable. Consent for publicationNot applicable. Conflict of InterestThe authors declare no competing interests. Conflict of Interest The authors declare no competing interests."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. This publication has been produced with the support of the Integrated Infrastructure Operational Program for the project New possibilities for laboratory diagnostics and massive screening of SARS-Cov-2 and identification of mechanisms of virus behavior in the human body, ITMS: 313011AUA4, co-financed by the European Regional Development Fund."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025